Medical Devices Ordinance
(MedDO)


Open article in different language:  DE  |  FR  |  IT
Art. 104abis Placing information about the authorised representative 141

For class I devices and for sys­tems and pro­ced­ure packs that are placed on the mar­ket in ac­cord­ance with the new le­gis­la­tion, the in­form­a­tion spe­cified in An­nex 1 Chapter III Sec­tion 23.2 let­ter d EU-MDR142 about the au­thor­ised rep­res­ent­at­ive in ac­cord­ance with Art­icle 51 para­graph 1 or 5 of this Or­din­ance may be in­cluded in a doc­u­ment ac­com­pa­ny­ing the device un­til 31 Ju­ly 2023.

141 In­ser­ted by An­nex 5 No 1 of the O of 4 May 2022 on In Vitro Dia­gnost­ic Med­ic­al Devices, in force since 26 May 2022 (AS 2022 291).

142 See the foot­note to Art. 4 para. 1 let. f.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden